lanthanum hydroxide has been researched along with Vascular Calcification in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bu, R; Gao, J; Han, R; Hao, J; Li, B; Li, G; Liu, H; Liu, Y; Sun, L; Wang, S; Zhao, J; Zhao, L | 1 |
| An, M; Bu, R; Cao, X; Gao, J; Gao, Y; Gu, C; Guo, M; Han, R; Hao, J; Li, B; Li, G; Liu, H; Liu, Y; Meng, Y; Su, C; Sun, L | 1 |
2 other study(ies) available for lanthanum hydroxide and Vascular Calcification
| Article | Year |
|---|---|
Lanthanum hydroxide inhibits vascular calcification by regulating the HIF-1 pathway.
Topics: Animals; Cardiovascular Diseases; Lanthanum; Phosphorus; Rats; Renal Insufficiency, Chronic; Vascular Calcification | 2022 |
Metabolomics of clinical samples reveal the treatment mechanism of lanthanum hydroxide on vascular calcification in chronic kidney disease.
Topics: Amino Acid Transport Systems, Neutral; Humans; Kidney Failure, Chronic; Lanthanum; Metabolomics; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Renal Insufficiency, Chronic; TOR Serine-Threonine Kinases; Vascular Calcification | 2022 |